Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

toothbrush

- PMLiVE

FDA announces rapid rollout of AI system to accelerate drug review process

The move follows the completion of a new AI-assisted scientific review pilot

The (clinical) trials and tribulations of gene therapy – why meaningful patient engagement strategies matter

By Sarah Mohamad and Lauren Coleman-Bennett

Amiculum

- PMLiVE

Apiary invests in life sciences performance marketing specialist performance-io

The investment will support the agency’s growth, service expansion and international presence

- PMLiVE

Tiziana Life Sciences’ intranasal MS candidate shows promise in open-label study

Approximately 2.9 million people worldwide are living with the neurodegenerative disease

- PMLiVE

The Weber Shandwick Collective appoints Lucie Harper as president of Health, UK

Harper has most recently been serving as president of integrated communications at Real Chemistry

- PMLiVE

Are Clinicians Still Feeling the Burn? A Look at HCP Mental Health and Well-Being

One of the most critical topics to address in health care today is the mental health and well-being of physicians and other healthcare professionals. The 2020 COVID-19 pandemic shined a...

Medscape Education

- PMLiVE

Eli Lilly and Alchemab Therapeutics enter ALS agreement worth up to $415m

The deal follows the companies’ earlier partnership to advance candidates for the neurodegenerative disease

- PMLiVE

Johnson & Johnson shares long-term results for Tremfya in ulcerative colitis

More than 2.5 million people in Europe are affected by the inflammatory bowel disease

- PMLiVE

MHRA approves Bavarian Nordic’s chikungunya vaccine Vimkunya

Approximately 620,000 cases of the mosquito-borne viral disease were reported worldwide in 2024

- PMLiVE

Examining the health of the pharma: patient group relationship

Explore the positive aspects and areas for improvement in the relationship between patient advocacy groups and pharma companies when participating in research, educational initiatives and awareness campaigns.

Say Communications

- PMLiVE

AstraZeneca’s Calquence approved by EC for first-line mantle cell lymphoma use

The drug is now the only BTK inhibitor to be approved in the EU for first-line MCL

- PMLiVE

Bristol Myers Squibb’s injectable Opdivo formulation granted MHRA for solid tumours

The new formulation reduces administration time from 30-to-60 minutes to three-to-five minutes

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links